Intratio
Loading...
Skip to main content
Model output · Signal date Oct. 14, 2026

Daily SignalsNeutral

2489 companies scored · 2026-10-14 run in progress: 1692 of ~5379 signals so far · Total · absolute moveSwitch to Alpha · 30D 90D

Signal date 2026-10-14 Cut-offs from the 2026-10-13 run
Companies scored 2489 IC ≥ 0 · market cap ≥ $100M
Median forecast +1.01% Total · 30D
Long–short spread +2.21% Strong Buy minus Strong Sell, mean
Median IC 0.29 Spearman · 30D
Rating changes ▲ 92 ▼ 76 vs the previous run
Cross-section

Distribution of the day's forecasts

30D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).

Signals · Neutral

67 companies

Sorted by 30D forecast ↓

# Ticker Sector IC Mkt cap Rating 30D 90D Δ
1 ADMAADMA BIOLOGICS, INC. Life Sciences 0.51 $2.3B Neutral +1.11% +3.51% ·
2 AQSTAquestive Therapeutics, Inc. Life Sciences 0.14 $586M Neutral +1.11% +4.31% ·
3 PTGXProtagonist Therapeutics, Inc Life Sciences 0.00 $9.0B Neutral +1.11% +4.02% ·
4 DBVTDBV Technologies S.A. Life Sciences 0.18 $2.7B Neutral +1.10% +1.52% ·
5 PEPGPepGen Inc. Life Sciences 0.38 $173M Neutral +1.10% +2.48% ▼ 1
6 ALKSAlkermes plc. Life Sciences 0.32 $6.7B Neutral +1.09% +2.92% ·
7 AMRNAMARIN CORP PLC\UK Life Sciences 0.14 $4.9B Neutral +1.09% +2.46% ·
8 SNDXSyndax Pharmaceuticals Inc Life Sciences 0.00 $1.2B Neutral +1.09% +3.48% ·
9 ENTAENANTA PHARMACEUTICALS INC Life Sciences 0.46 $358M Neutral +1.08% +3.91% ·
10 OMEROMEROS CORP Life Sciences 0.46 $1.4B Neutral +1.08% +3.84% ·
11 RIGLRIGEL PHARMACEUTICALS INC Life Sciences 0.20 $881M Neutral +1.08% +3.99% ·
12 VNDAVanda Pharmaceuticals Inc. Life Sciences 0.37 $274M Neutral +1.08% +3.02% ·
13 ZBIOZenas BioPharma, Inc. Life Sciences 0.19 $1.7B Neutral +1.08% +4.57% ·
14 PTCTPTC THERAPEUTICS, INC. Life Sciences 0.25 $5.0B Neutral +1.07% +2.62% ·
15 ELTPELITE PHARMACEUTICALS INC /NV/ Life Sciences 0.37 $275M Neutral +1.06% +3.62% ·
16 EXELEXELIXIS, INC. Life Sciences 0.30 $14.7B Neutral +1.06% +3.91% ·
17 TARSTarsus Pharmaceuticals, Inc. Life Sciences 0.05 $3.3B Neutral +1.06% +3.69% ·
18 BCRXBIOCRYST PHARMACEUTICALS INC Life Sciences 0.59 $2.1B Neutral +1.05% +3.59% ·
19 SMMTSummit Therapeutics Inc. Life Sciences 0.33 $13.7B Neutral +1.05% +3.06% ·
20 GALTGALECTIN THERAPEUTICS INC Life Sciences 0.10 $390M Neutral +1.04% +2.83% ·
21 NBPNovaBridge Biosciences Life Sciences 0.59 $342M Neutral +1.04% +3.08% ·
22 SIGASIGA TECHNOLOGIES INC Life Sciences 0.46 $221M Neutral +1.04% +2.67% ·
23 PLYXPolaryx Therapeutics, Inc. Life Sciences 0.64 $100M Neutral +1.02% +3.10% ·
24 HALOHALOZYME THERAPEUTICS, INC. Life Sciences 0.49 $12.4B Neutral +1.01% +3.21% ·
25 IMCRImmunocore Holdings plc Life Sciences 0.12 $1.4B Neutral +1.01% +3.03% ·
26 PHATPhathom Pharmaceuticals, Inc. Life Sciences 0.24 $566M Neutral +1.01% +3.65% ·
27 AMRXAmneal Pharmaceuticals, Inc. Life Sciences 0.02 $6.2B Neutral +0.99% +2.97% ·
28 CGENCOMPUGEN LTD Life Sciences 0.42 $196M Neutral +0.99% +3.04% ·
29 HRMYHarmony Biosciences Holdings, Inc. Life Sciences 0.31 $2.2B Neutral +0.99% +3.11% ·
30 LENZLENZ Therapeutics, Inc. Life Sciences 0.58 $107M Neutral +0.98% +2.69% ·
31 ALNYALNYLAM PHARMACEUTICALS, INC. Life Sciences 0.44 $29.9B Neutral +0.97% +1.00% ·
32 NATRNATURES SUNSHINE PRODUCTS INC Life Sciences 0.61 $225M Neutral +0.97% +1.93% ·
33 AXSMAxsome Therapeutics, Inc. Life Sciences 0.04 $8.2B Neutral +0.96% +1.77% ·
34 GILDGILEAD SCIENCES, INC. Life Sciences 0.26 $183.4B Neutral +0.96% +2.61% ·
35 NRIXNurix Therapeutics, Inc. Life Sciences 0.23 $2.3B Neutral +0.96% +2.65% ·
36 ELANElanco Animal Health Inc Life Sciences 0.23 $11.2B Neutral +0.95% +3.40% ·
37 CYTKCYTOKINETICS INC Life Sciences 0.20 $8.6B Neutral +0.93% +2.80% ·
38 LFCRLIFECORE BIOMEDICAL, INC. \DE\ Life Sciences 0.04 $243M Neutral +0.93% +2.15% ·
39 QUREuniQure N.V. Life Sciences 0.37 $1.3B Neutral +0.93% +2.08% ·
40 CRVSCorvus Pharmaceuticals, Inc. Life Sciences 0.33 $792M Neutral +0.92% +2.14% ·
41 TLRYTilray Brands, Inc. Life Sciences 0.01 $458M Neutral +0.91% +2.58% ·
42 COLLCOLLEGIUM PHARMACEUTICAL, INC Life Sciences 0.51 $701M Neutral +0.90% +1.98% ·
43 ORMPORAMED PHARMACEUTICALS INC. Life Sciences 0.11 $173M Neutral +0.90% +3.79% ·
44 BMRNBIOMARIN PHARMACEUTICAL INC Life Sciences 0.30 $10.5B Neutral +0.89% +1.67% ·
45 CGCCanopy Growth Corp Life Sciences 0.27 $323M Neutral +0.88% +3.81% ·
46 KODKodiak Sciences Inc. Life Sciences 0.20 $5.8B Neutral +0.88% +4.50% ·
47 PCRXPacira BioSciences, Inc. Life Sciences 0.31 $1.4B Neutral +0.87% +1.88% ·
48 MSLESatellos Bioscience Inc. Life Sciences 0.39 $111M Neutral +0.86% +2.41% ·
49 ANABANAPTYSBIO, INC Life Sciences 0.56 $1.3B Neutral +0.85% +3.05% ·
50 LABSTANDARD BIOTOOLS INC. Life Sciences 0.27 $259M Neutral +0.85% +2.29% ·
1–50 of 67 Previous Next
Since the previous run

Rating changes

▲ 92▼ 76
Which companies were upgraded or downgraded is part of the paid plans.
Next step

Unlock the full ranking

Every company's rating, its 30- and 90-day forecasts, the forecast and IC-weighted rankings, the daily rating changes and CSV export.

See plans Create a free account
Methodology

Ratings are relative: the forecasts of the latest complete daily run (2026-10-13) are ranked and cut at the 15th, 35th, 65th and 85th percentiles, so Strong Sell is the bottom 15%, Sell the next 20%, Neutral the middle 30%, Buy the next 20% and Strong Buy the top 15%. Expected absolute price move over the horizon, market included. This is the number a price target is built from. IC is the company's Spearman information coefficient between its past forecasts and the realised returns at the selected horizon; IC-weighted ranking multiplies each forecast by its IC (negative IC counts as zero). Δ is the rating move since the company's previous signal, in rating steps. Each company shows its latest signal, including one from a run still in progress; every signal is rated against the cut-offs above. Quantitative research output, not investment advice.